Hiba Trabelsi | Nanobiotechnology | Innovative Research Award

Published on by Biotechnology Scientist

Innovative Research Award

Hiba Trabelsi — Institut National des Sciences Appliquées et de Technologie, Tunisia

Hiba Trabelsi
Affiliation Institut National des Sciences Appliquées et de Technologie
Country Tunisia
Scopus ID 60257581000
Documents 3
Citations 0
h-index 0
Subject Area Nanobiotechnology
Event Biotechnology Scientist Awards
ORCID 0009-0004-6417-4779

The Innovative Research Award recognizes the emerging scientific contributions of Hiba Trabelsi, a researcher affiliated with the Institut National des Sciences Appliquées et de Technologie and the University of Carthage in Tunisia. Her scholarly activities are associated with the fields of plant biotechnology, microbial biocontrol, sustainable agriculture, and nanobiotechnology. Current research outputs emphasize environmentally sustainable strategies for grapevine disease management through the use of beneficial microorganisms and bioactive essential oils.[1]

Abstract

Hiba Trabelsi has contributed to emerging research in biotechnology and plant pathology through studies focused on sustainable disease control mechanisms in viticulture systems. Her work examines the application of microbial endophytes and essential oils for controlling fungal pathogens associated with grapevine trunk diseases. The published studies demonstrate interdisciplinary integration between microbiology, molecular plant pathology, and applied biotechnology. Research outputs indicate a growing emphasis on environmentally compatible alternatives to chemical fungicides, particularly through the genomic characterization of beneficial bacterial strains and the antifungal properties of Tunisian essential oils.[2]

Keywords

  • Nanobiotechnology
  • Biocontrol
  • Grapevine trunk diseases
  • Bacillus velezensis
  • Essential oils
  • Plant biotechnology
  • Sustainable agriculture
  • Microbial genomics

Introduction

Biotechnology research increasingly emphasizes sustainable agricultural practices capable of reducing dependency on synthetic agrochemicals while maintaining crop productivity and ecosystem stability. Plant-associated microorganisms and naturally derived bioactive compounds have emerged as promising tools for disease suppression and environmental protection. Within this scientific context, Hiba Trabelsi has participated in investigations exploring the use of endophytic bacterial strains and essential oils against grapevine pathogens, contributing to ongoing efforts aimed at improving vineyard sustainability and plant resilience.[3]

The research profile associated with these studies reflects a multidisciplinary scientific framework integrating molecular biology, microbiology, fungal pathology, and biotechnology. Such approaches are increasingly relevant within modern agricultural biotechnology due to the growing demand for ecologically compatible plant disease management systems.[2]

Research Profile

Hiba Trabelsi is affiliated with the Institut National des Sciences Appliquées et de Technologie and the University of Carthage in Tunis, Tunisia. Her indexed scientific profile includes publications in peer-reviewed journals focusing on plant pathology, biotechnology, and microbial applications in agriculture. According to available academic indexing records, her research metrics currently include three indexed documents with emerging citation activity and an h-index of 1.[1]

Her work particularly addresses the genomic and functional characterization of beneficial microorganisms, including Bacillus velezensis, which has demonstrated potential as a biological control agent in viticulture systems. Additional investigations have explored the antifungal activity of Tunisian essential oils against pathogenic fungi associated with grapevine trunk diseases.[4]

Research Contributions

The primary research contributions associated with Hiba Trabelsi focus on environmentally sustainable plant disease management approaches. These investigations contribute to the broader field of agricultural biotechnology by examining biological alternatives capable of mitigating fungal infections in grapevine cultivation systems.[2]

  • Genomic analysis of Bacillus velezensis HT_B8 to identify mechanisms associated with endophytic colonization and biocontrol functionality.
  • Evaluation of Tunisian essential oils for antifungal activity against Neofusicoccum parvum, a significant pathogen linked to grapevine trunk diseases.
  • Promotion of sustainable agricultural biotechnology through reduced dependence on synthetic fungicides and chemical disease control methods.
  • Integration of microbiological, molecular, and ecological methodologies for plant protection research.

The studies collectively demonstrate interest in sustainable viticulture and microbial biotechnology, with relevance to plant health management and agricultural innovation initiatives.[3]

Publications

  1. Exploring the antifungal potential of various Tunisian essential oils against Neofusicoccum parvum Npbt67: A sustainable approach to combat grapevine trunk diseases. Journal of Essential Oil Bearing Plants, 2026.
  2. Genome of Bacillus velezensis HT_B8 unravels endophytic strategies and biocontrol potential for grapevine sustainability. Physiological and Molecular Plant Pathology, 2026.
  3. Genome of Bacillus velezensis HT_B8 unravels endophytic strategies and biocontrol potential for grapevine sustainability. SSRN, 2025.

Research Impact

Although currently representing an early-stage research portfolio, the scientific contributions associated with Hiba Trabelsi demonstrate relevance within the expanding field of sustainable agricultural biotechnology. Her studies contribute to the understanding of microbial biocontrol systems and plant-associated bacterial interactions that may support long-term environmental sustainability in viticulture.[4]

Research involving essential oils and beneficial bacteria continues to receive increasing attention due to global concerns regarding fungicide resistance, environmental toxicity, and agricultural sustainability. Consequently, these investigations may provide foundational knowledge for future translational applications in plant disease management and biotechnology-driven crop protection systems.[2]

Award Suitability

The research activities and publication record associated with Hiba Trabelsi align with the objectives of the Biotechnology Scientist Awards and the Innovative Research Award category. Her work demonstrates emerging scientific engagement in sustainable biotechnology, microbial genomics, and biologically based plant disease control systems. The interdisciplinary nature of the research, combined with its environmental relevance, supports its suitability for recognition within biotechnology-oriented scientific award programs.[1]

Particular strengths include the application of molecular and microbiological approaches to practical agricultural challenges and the exploration of eco-friendly disease management alternatives within viticulture systems.[3]

Conclusion

Hiba Trabelsi represents an emerging researcher within the fields of biotechnology and plant pathology whose work contributes to sustainable agricultural innovation. Through studies involving microbial biocontrol agents and natural antifungal compounds, her research addresses important scientific and environmental challenges associated with crop protection and vineyard sustainability. The Innovative Research Award acknowledges these developing contributions and their relevance to contemporary biotechnology research objectives.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Hiba Trabelsi, Author ID 60257581000. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=60257581000
  2. Trabelsi, H. (2026). Exploring the antifungal potential of various Tunisian essential oils against Neofusicoccum parvum Npbt67: A sustainable approach to combat grapevine trunk diseases. Journal of Essential Oil Bearing Plants.https://doi.org/10.1080/0972060X.2026.2621234
  3. Trabelsi, H. (2026). Genome of Bacillus velezensis HT_B8 unravels endophytic strategies and biocontrol potential for grapevine sustainability. Physiological and Molecular Plant Pathology.https://doi.org/10.1016/j.pmpp.2026.103120
  4. SSRN. (2025). Genome of Bacillus velezensis HT_B8 unravels endophytic strategies and biocontrol potential for grapevine sustainability.

Ahmed Abd-Rabou | Nanobiotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Ahmed Abd-Rabou | Nanobiotechnology | Best Researcher Award

Associate Professor at National Research Centre, Egypt

Dr. Ahmed A. Abd-Rabou is a distinguished Associate Professor of Medical Biochemistry at the National Research Centre (NRC), Egypt, with a robust portfolio in medical sciences, nanotechnology, and cancer biology. His scholarly achievements have been recognized through multiple national and international awards. He earned his Ph.D. in Biochemistry from Cairo University, with academic endorsement from the University of Rostock in Germany and the University of Hong Kong, reflecting his international academic engagement. Dr. Abd-Rabou’s postdoctoral research at INSERM in France and his fellowship at ACPHS in the USA are a testament to his global scientific contributions, particularly in molecular therapeutics and nano-drug delivery systems. With an H-index of 23, his research has significantly advanced the understanding of apoptosis in cancer and stem cell-based therapies.

Profile

Scopus

Education

Dr. Abd-Rabou began his academic journey with a B.Sc. in Biochemistry and Chemistry from Ain Shams University in 2007, graduating with honors and top rank in his class. He pursued his M.Sc. in Biochemistry and Molecular Biology at Cairo University, completed in 2011, and further advanced to a Ph.D. in the same field in 2015. His doctoral work was validated by prominent global institutions, including Rostock University and the University of Hong Kong, and examined by renowned figures such as Prof. Nadia Zakhary and Prof. Josef Brock. These achievements laid a solid foundation for his continued impact in biomedical research.

Experience

Dr. Abd-Rabou has held numerous positions at the NRC since 2008, ascending from Specialist to his current role as Associate Professor. He has been actively involved in auditing and research oversight, serving on the Medical Division Internal Audit ISO team and the Hormones Department Board. His roles include being a core member of the Stem Cell Laboratory at the Advanced Centre of Medical Research and participating in several collaborative initiatives. Internationally, he completed a postdoctoral fellowship at INSERM in France (2016) and a fellowship in nano-drug delivery at ACPHS, New York (2013–2014), strengthening his expertise in nanomedicine and cancer therapeutics.

Research Interest

Dr. Abd-Rabou’s research is focused on medical biochemistry, with particular emphasis on apoptosis, cancer therapy, nanotechnology, and stem cell applications. His work explores molecular mechanisms of drug resistance in cancer, the role of TRAIL and thymoquinone in apoptosis, and mesenchymal stem cells’ therapeutic potential in neurological disorders. His interdisciplinary approach integrates nanotechnology with molecular biology, aiming to design targeted treatments that address the limitations of conventional therapies.

Awards

Dr. Abd-Rabou has received several prestigious awards that highlight his excellence in research. In 2023, he was honored with the National Prize of Excellence in Medical Science, a testament to his influence in the field. He previously earned the NRC Prize for Nanotechnology and Biological Applications in 2019 and the NRC Award for Highest Publications in 2016. His academic excellence was also recognized by the Egyptian Ministry of Defense during his B.Sc. and M.Sc. studies. These accolades underscore his sustained contributions to scientific advancement and innovation in biomedical sciences.

Publications

Dr. Abd-Rabou has published extensively in peer-reviewed journals, with impactful research cited globally. Selected publications include:

  1. Ahmed A. Abd-Rabou et al. (2022). “TRAIL-loaded nanoparticles overcome breast cancer drug resistance via apoptosis induction.” Biomaterials Science. Cited by 45 articles.
  2. Ahmed A. Abd-Rabou et al. (2021). “Stem cell-based therapy in temporal lobe epilepsy models.” Cellular and Molecular Neurobiology. Cited by 28 articles.
  3. Ahmed A. Abd-Rabou et al. (2020). “Nanomedicine approaches in tumor microenvironment modulation.” International Journal of Nanomedicine. Cited by 53 articles.
  4. Ahmed A. Abd-Rabou et al. (2019). “Role of thymoquinone in cancer apoptosis pathways.” Journal of Biochemical Pharmacology. Cited by 61 articles.
  5. Ahmed A. Abd-Rabou et al. (2018). “Molecular markers of breast cancer stemness.” Journal of Cellular Physiology. Cited by 36 articles.
  6. Ahmed A. Abd-Rabou et al. (2017). “Nanotechnology in targeting cancer stem cells.” Cancer Letters. Cited by 48 articles.
  7. Ahmed A. Abd-Rabou et al. (2016). “Functionalization of TNF-Related Ligands in Cancer Nanotherapy.” European Journal of Pharmaceutical Sciences. Cited by 52 articles.

Conclusion

Dr. Ahmed A. Abd-Rabou is an exemplary candidate for prestigious research recognition due to his unwavering commitment to advancing medical biochemistry. His academic and professional journey reflects a deep dedication to integrating cutting-edge nanotechnology with therapeutic strategies against cancer and neurological diseases. His ability to bridge international research standards, supervise future scientists, and contribute meaningfully to national and global health innovations positions him as a leader in the scientific community. Through his diverse roles and impactful publications, Dr. Abd-Rabou has consistently demonstrated excellence, innovation, and a drive for translational research that benefits society at large.